logo image
search icon
Global AI-Based Clinical Trial Solution Providers Market

AI-Based Clinical Trial Solution Providers Market Size, Share & Trends Analysis Report By Target Therapeutics (Cardiovascular Disorders, CNS Disorders, Infectious Disorders, Metabolic Disorders, Oncological Disorders, and Other Disorders), By Trial Phase, By End Users, Region And Segment Forecasts, 2023-2031.

Report ID : 1082 | Published : 2024-03-15 | Pages: 180 | Format: PDF/EXCEL

The AI-Based Clinical Trial Solution Providers Market Size is valued at 1560.0 Million in 2022 and is predicted to reach 8926.2 Million by the year 2031 at a 21.5 % CAGR during the forecast period for 2023-2031.

AI-Based Clinical Trial Solution Providers Market

Artificial Intelligence is a set of smart technologies that develop and learn from data and perform tasks based on previous experience. The process, clinical trials are crucial that enable both innovators and regulators to assess the efficacy of a candidate drug. The use of AI in clinical trial saves time and cost efficiencies by providing faster insights to form the decision. AI helps investigators to answer some questions, including how to construct study design, site identification & patient recruitment for clinical research, and digitize adverse drug reaction (ADR) documents in pharmacovigilance. Successfully developing a novel therapeutic intervention required around 10 years of time and cost around USD 2.5 billion. However, the use of technology like artificial intelligence in a clinical trial help to save a huge amount of money and time.

Increasing the number of strategic alliances in deployment of Artificial Intelligence (AI) in clinical trials aims to reduce time and expenditure during clinical developmental phases is expected to create lucrative growth in market in the near future. Additionally, regulators worldwide have released guidelines that encourage biopharma companies to use real-world evidence strategies. For instance, US FDA has passed the 21st Century Cures Act, in 2016, that was designed to help bring new innovations and advances to patients more efficiently and faster.

Market Segmentation

Global AI-Based Clinical Trial Solution Provider market is segmented on the basis of target therapeutic area, trial phase, end users and region. Based on the therapeutic area, the market is divided into cardiovascular disorders, cns disorders, infectious disorders, metabolic disorders, oncological disorders and other disorders. Based on the trial phase, the market is divided into early phase 1, phase 1, phase 2, phase 3 and phase 4. Based on the end users, the market is divided into pharmaceutical companies, academia and other users. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.

Competitive Landscape

Some of The Key Players in The AI-Based Clinical Trial Solution Providers Market:

  • Antidote Technologies, Inc.
  • AiCure, LLC
  • Deep 6 AI
  • Deep Lens Inc.
  • Innoplexus
  • Intelligencia.ai
  • MEDIAN Technologies
  • Mendel.ai
  • Phesi
  • Saama Technologies
  • AI, Inc.
  • Trials.ai
  • Other Prominent Players

The AI-Based Clinical Trial Solution Providers Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 1560.0 Million

Revenue Forecast In 2031

USD 8926.2 Million

Growth Rate CAGR

CAGR of 21.5 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Target Therapeutics, By Trial Phase, By End Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Antidote Technologies, Inc., AiCure, LLC, Deep 6 AI, Deep Lens Inc., Innoplexus, Intelligencia.ai, MEDIAN Technologies, Mendel.ai, Phesi, Saama Technologies, Unlearn.AI, Inc. and Trials.ai, and others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

  • Antidote Technologies, Inc.
  • AiCure, LLC
  • Deep 6 AI
  • Deep Lens Inc.
  • Innoplexus
  • Intelligencia.ai
  • MEDIAN Technologies
  • Mendel.ai
  • Phesi
  • Saama Technologies
  • Unlearn.AI, Inc.
  • Trials.ai

Global AI-Based Clinical Trial Solution Provider Market Segmentation:

Global AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) by Target Therapeutics

  • Cardiovascular Disorders
  • CNS Disorders
  • Infectious Disorders
  • Metabolic Disorders
  • Oncological Disorders
  • Other Disorders

AI-Based Clinical Trial Solution Providers Market

Global AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) Based on Trial Phase

  • Early Phase 1
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Global AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) Based on end users

  • Pharmaceutical Companies
  • Academia and Other Users

Global AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) Based on Region

Europe AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) by Country

  • U.S.
  • Canada

Asia Pacific AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa AI-Based Clinical Trial Solution Provider Market Revenue (US$ Mn) by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the AI-Based Clinical Trial Solution Providers Market Size?

The AI-Based Clinical Trial Solution Providers Market is expected to grow at a 21.5 % CAGR during the forecast period for 2023-2031.

Antidote Technologies, Inc., AiCure, LLC, Deep 6 AI, Deep Lens Inc., Innoplexus, Intelligencia.ai, MEDIAN Technologies, Mendel.ai, Phesi, Saama Techno

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach